Home›Research›Compare›BPC-157 vs GHK-Cu
Peptide ComparisonBPC-157 vs GHK-Cu
BPC-157
Body Protection Compound 157
Half-life: Under 30 minutes (plasma); no human PK data
638 providers listed
GHK-Cu
Copper Peptide
Half-life: 15–30 minutes
378 providers listed
BPC-157 and GHK-Cu target different goals — BPC-157 for tissue repair across tendon, muscle, nerve, and gut — most broadly studied recovery peptide, GHK-Cu for collagen and elastin synthesis promotion via fibroblast activation. They're compared here for reference, not as direct substitutes.
BPC-157
Half-life
Under 30 minutes (plasma); no human PK data
GHK-Cu
Half-life
15–30 minutes
| Your goal | Better option |
|---|---|
| Tendon, ligament, and GI healing research | BPC-157 |
| Skin collagen and wound repair research | GHK-Cu |
| Hair follicle growth research | GHK-Cu |
| Anti-inflammatory and pain reduction research (animal models) | BPC-157 |
| More provider options (638 vs 378) | BPC-157 |
| Topical application research | GHK-Cu |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
BPC-157
GHK-Cu
BPC-157
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approac…
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.
+10 more
GHK-Cu
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration th…
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and ac…
Glycyl-L-histidyl-L-lysine-Cu2(+) (GHK-Cu) Attenuates CuSO(4) or LPS induced-inflammation in Zebrafish larvae…
+3 more
About BPC-157
BPC-157 is believed to accelerate angiogenesis and upregulate growth hormone receptors locally at injury sites. It appears to promote fibroblast migration and collagen synthesis, contributing to faster tissue remodelling. Animal studies suggest systemic effects via modulation of the dopaminergic and serotonergic systems, though human data remain limited.
About GHK-Cu
GHK-Cu promotes the synthesis of collagen, elastin, glycosaminoglycans, and decorin, contributing to tissue remodelling and wound contraction. It modulates the activity of matrix metalloproteinases (MMPs) — stimulating wound-healing MMPs while suppressing those that degrade healthy tissue. Genomic analysis has identified GHK-Cu as a modulator of over 4,000 genes, including those governing antioxidant defences and anti-inflammatory pathways.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
BPC-157
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
global — WADA
BPC-157 is on the WADA Prohibited List at all times (S0, Non-Approved Substances), effective 1 January 2022. It has no FDA approval and no adequate human clinical trial.
sourceGHK-Cu
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Commonly stacked
EmergingBPC-157 and GHK-Cu are reported to work together. Research suggests GHK-Cu and BPC-157 may produce complementary tissue repair and anti-inflammatory effects when combined. GHK-Cu is studied for copper-dependent collagen synthesis and antioxidant gene activation, while BPC-157 supports angiogenesis and growth factor expression.
BPC-157
GHK-Cu
Research suggests GHK-Cu and BPC-157 may produce complementary tissue repair and anti-inflammatory effects when combined. GHK-Cu is studied for copper-dependent collagen synthesis and antioxidant gene activation, while BPC-157 supports angiogenesis and growth factor expression.
TB-500
Research suggests BPC-157 and TB-500 may produce enhanced tissue repair effects when combined. BPC-157 is studied for angiogenesis and gut-protective properties, while TB-500 promotes actin assembly and cell migration — complementary mechanisms in healing models.
Anticoagulants / blood thinners
Research notes that BPC-157 promotes angiogenesis and may influence platelet and vascular function in healing models. Combined use with anticoagulant medications may warrant monitoring. Consult your prescriber before combining.
GHK-Cu
BPC-157
Research suggests GHK-Cu and BPC-157 may produce complementary tissue repair and anti-inflammatory effects when combined. GHK-Cu is studied for copper-dependent collagen synthesis and antioxidant gene activation, while BPC-157 supports angiogenesis and growth factor expression.
Epithalon
Research suggests Epithalon and GHK-Cu may produce complementary longevity-associated effects when combined. Epithalon is studied for telomere maintenance and pineal function, while GHK-Cu is studied for antioxidant gene expression and tissue remodeling — different mechanisms in aging research.
BPC-157
GHK-Cu
Where to source these peptides
BPC-157
638 listed
Browse directory →
Providers offeringGHK-Cu
378 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). BPC-157 vs GHK-Cu — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/bpc-157/ghk-cu